High Prevalence of Anti‐phospholipid Antibodies and Anti‐thyroglobulin Antibody in Patients with Hepatitis C Virus Infection Treated with Interferon‐α

The American Journal of Gastroenterology

Volumn 90, Issue 7, 1995, Pages 1138-1141

  Matsuda, Juzo ^a   Saitoh, Noriko ^a   Gotoh, Moritaka ^a   Gohchi, Kengo ^a   Tsukamoto, Miyo ^a   Syoji, Sadashi ^a   Miyake, Kazuhiko ^a   Yamanaka, Masani ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; DNA ANTIBODY; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ADULT; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNITY; FEMALE; HEPATITIS C; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; THROMBOGENESIS; VIRUS INFECTION;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; DNA; FEMALE; HEPATITIS C; HUMAN; INTERFERON-ALPHA; IODIDE PEROXIDASE; MALE; MIDDLE AGE; PHOSPHATIDIC ACIDS; PHOSPHATIDYLCHOLINES; PREVALENCE; THYROGLOBULIN;

EID: 0029044238     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1995.tb09432.x     Document Type: Article

References (27)

1. Lupus anticoagulant: Misnomer, paradox, riddle, epiphenomenon
2. Antiphospholipid antibodies
3. Antiphospholipid antibodies
4. Antiphospholipid antbodies and thrombosis: A consequence, coincidence, or cause
5. 2‐glycoprotein I (apolipoprotein H
6. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor
7. 2‐glucoprotein I as an antigen
8. 2‐glycoprotein 1 complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection
9. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor
10. 2‐glycoprotein I antibody in patients with systemic lupus erythematosus and patients with syphilis
11. Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B
12. Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B
13. Re‐evaluation of alpha interferon treatment of chronic hepatitis B using polymerase chain reaction
14. Hemolytic anemia secondary to interferon treatment for chronic B hepatitis
15. Peripheral blood lyphocyte subsets in patients with chronic hepatitis C: Effects of interferon treatment
16. Variability in the expression of a beta 2‐microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon
17. 2‐glycoprotein I (apolipoprotein H)‐ dependent anticardiolipin antibody in human imunodeficiency virus‐1‐positive and negative hemophiliacs
18. High prevalence of anti‐cardiolipin antibody, C1q‐, C3d‐, and mRF‐IgG immune complex and anti‐nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type‐1
19. 2 glycoprotein I in the rat: Isolation from serum and demonstration in lipoprotein density fractions
20. Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis
21. Patterns of anti‐phospholipid antibody specificities
22. Phospholipid specificity and requirement of β2‐glycoprotein I for reactivity of antibodies from patients with primary antiphospholipid syndrome
23. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy
24. Autoimmune manifestations of human immunodeficiency virus (HIV) infection
25. Association of human imunodeficiency virus infection and autoimmune phenomena
26. Anti‐LKM‐1 antibodies determined by use of recombinant P4502D6 in ELISA and Western blot and their association with anti‐HCV and HCV‐RNA
27. Genetic and immunologic factors in autoimmune diseases